Home > Specialties > IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, BCL2

IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, BCL2

Definition : Molecular assay reagents intended to identify mutations in the B-cell CLL/lymphoma 2 (BCL2) gene, located at chromosome 18q2, which encodes for an outer mitochondrial membrane protein that suppresses apoptotic cell death. Genetic mutations (rearrangements) involving the BCL2 gene are indicators of follicular lymphoma type II, chronic lymphatic leukemia, and/or B-cell lymphoma.

Entry Terms : "Genetic Rearrangement Gene Mutation Detection Reagents" , "Lymphoma Gene Mutation Detection Reagents" , "Hodgkin's Lymphoma Gene Mutation Detection Reagents" , "Diffuse Large Cell Lymphoma (DLLC) Gene Mutation Detection Reagents" , "Follicular Lymphomas Gene Mutation Detection Reagents" , "BCL2 Gene Mutation Detection Reagents" , "Reagents, Molecular Assay, Gene Anomaly, Mutation, BCL2"

UMDC code : 24314

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-4 of 4 Match(es).

ACROBiosystems Inc

Company Type: Parent

Genomind

Company Type: Parent

Mayo Medical Laboratories

Company Type: Parent

Novus Biologicals LLC

Company Type: Parent

1-4 of 4 Match(es).

 

Medical Product Guide Optometric Management Product Guide